Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells

被引:52
作者
Midorikawa, S [1 ]
Sanada, H [1 ]
Hashimoto, S [1 ]
Watanabe, T [1 ]
机构
[1] Fukushima Med Univ, Sch Med, Dept Internal Med 3, Fukushima 9601295, Japan
关键词
homocysteine; atherosclerosis; PAI-1; tPA; vascular endothelial cells; vascular smooth muscle cells; TGF beta; TNF alpha;
D O I
10.1006/bbrc.2000.2753
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In order to elucidate the relationship between homocysteine and the fibrinolytic system, we examined the effect of homocysteine on plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (tPA) gene expression and protein secretion in cultured human vascular endothelial and smooth muscle cells in vitro. PAI-1 mRNA and secreted protein levels were both enhanced by homocysteine in a dose dependent manner, with significant stimulation of PAI-1 secretion observed at concentrations greater than 0.5 mM homocysteine. In contrast, secretion and mRNA expression of tPA were not significantly altered by homocysteine stimulation. Secretion of TGF beta (transforming growth factor beta) and TNF alpha (tumor necrosis factor alpha), possible regulators of PAI-1 expression and secretion, were not stimulated by treatment with 1.0 mM homocysteine. These results suggests that hyperhomocysteinemia-induced atherosclerosis and/or thrombosis may be caused by homo cysteine-induced stimulation of PAI-1 gene expression and secretion in the vasuculatures by a mechanism independent from paracrine-autocrine activity of TGF beta and TNF alpha. (C) 2000 Academic Press.
引用
收藏
页码:182 / 185
页数:4
相关论文
共 27 条
[1]  
AZNAR J, 1988, BRIT HEART J, V59, P535
[2]   ELEVATED TOTAL PLASMA HOMOCYSTEINE, A RISK FACTOR FOR THROMBOSIS - RELATION TO COAGULATION AND FIBRINOLYTIC PARAMETERS [J].
BIENVENU, T ;
ANKRI, A ;
CHADEFAUX, B ;
MONTALESCOT, G ;
KAMOUN, P .
THROMBOSIS RESEARCH, 1993, 70 (02) :123-129
[3]  
DECLERCK PJ, 1988, BLOOD, V71, P220
[4]  
GILBERT RU, 1997, ATHEROSCLEROSIS, V132, P177
[5]  
GILBERT RU, 1996, J NUTR, V126, pS1290
[6]   HOMOCYSTEINE-INDUCED MODULATION OF TISSUE-PLASMINOGEN ACTIVATOR BINDING TO ITS ENDOTHELIAL-CELL MEMBRANE-RECEPTOR [J].
HAJJAR, KA .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2873-2879
[7]  
HAMSTEN A, 1986, BRIT HEART J, V55, P58
[8]   INCREASED PLASMA-LEVELS OF A RAPID INHIBITOR OF TISSUE PLASMINOGEN-ACTIVATOR IN YOUNG SURVIVORS OF MYOCARDIAL-INFARCTION [J].
HAMSTEN, A ;
WIMAN, B ;
DEFAIRE, U ;
BLOMBACK, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (25) :1557-1563
[9]   Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM [J].
Hofmann, MA ;
Kohl, B ;
Zumbach, MS ;
Borcea, V ;
Bierhaus, A ;
Henkels, M ;
Amiral, J ;
Fiehn, W ;
Ziegler, R ;
Wahl, P ;
Nawroth, PP .
DIABETES CARE, 1997, 20 (12) :1880-1886
[10]  
IAN MG, 1997, JAMA-J AM MED ASSOC, V277, P1775